PHK
MDCO

Point72 Hong Kong’s Medicines Co MDCO Stock Holding History

Point72 Hong Kong’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-199
Closed -$6K – 1544
2019
Q1 		$6K Buy
+199
New +$4.69K ﹤0.01% 809
2018
Q4 		– Sell
-218
Closed -$7K – 1358
2018
Q3 		$7K Buy
+218
New +$8.21K ﹤0.01% 686
2017
Q2 		– Sell
-192
Closed -$9K – 1120
2017
Q1 		$9K Buy
+192
New +$8.76K 0.01% 527

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Point72 Hong Kong's MDCO Position: Q2 2019 in Review

Point72 Hong Kong sold out of Medicines Co (MDCO) in Q2 2019, closing a stake of 199 shares — an estimated $6K sold.

Point72 Hong Kong first reported a position in MDCO in Q1 2017 and held it in 3 quarters. The position peaked at $9K in Q1 2017. 228 funds tracked by Wall St. Rank hold MDCO as of Q2 2019.

  • Point72 Hong Kong reported no remaining Medicines Co position as of Q2 2019 after selling out during the quarter.
  • Point72 Hong Kong sold 199 Medicines Co shares in Q2 2019, an estimated $6K.
  • Point72 Hong Kong first reported a position in Medicines Co in Q1 2017 and held it in 3 quarters.
  • Point72 Hong Kong's Medicines Co position peaked at $9K in Q1 2017.
  • 228 funds tracked by Wall St. Rank held Medicines Co as of Q2 2019.

Based on Point72 Hong Kong's 13F filing for Q2 2019, filed 14 Aug 2019.